Metabolic Health Articles - Page 33

FDA Approves Foundayo Weight Loss Pill, Igniting GLP-1 Showdown

The FDA has approved Foundayo weight loss pill from Eli Lilly on April 1 (ET), introducing a flexible oral GLP-1 option for adults with obesity or weight-related conditions—no food or water restrictions needed. Trial data shows superior weight loss over Rybelsus, averaging 15-20 pounds vs. 8-11 pounds in diabetes patients. This approval sets up a new showdown in the GLP-1 market dominated by injections like Wegovy and Zepbound.

Shotlee·Apr 4, 2026·5 min read

Peptide Therapy

MHRA Investigates UK Peptide Clinics Over Health Claims

The UK's Medicines and Healthcare products Regulatory Agency (MHRA) is investigating peptide clinics for making bold health claims about unregulated therapies. Clinics promote peptides like BPC-157 for injury recovery and MOTS-C for energy, despite scant human evidence. This Guardian-revealed probe highlights risks in the booming peptide market.

Shotlee·Apr 4, 2026·6 min read

GLP-1 Medications & Side Effects

Doctor Warns of 'Miserable' Constipation from Wegovy as NHS Expands to 1.2M

The NHS has expanded free Wegovy access to 1.2 million more people, but a doctor is urging caution over a 'miserable' side effect: constipation. Dr. Suraj Kukadia explains how GLP-1 medications like Wegovy slow digestion, leading to this common issue. Discover the mechanism and tips for those considering these weight loss jabs.

Shotlee·Apr 4, 2026·5 min read

GLP-1 Medications

Ozempic Users Reshape How America Dines Out

The rise of Ozempic and similar GLP-1 medications is dramatically altering dining out habits across America, with users ordering less food and leaving meals uneaten. Restaurants face revenue pressures as customers skip courses and reduce alcohol intake. Forward-thinking spots are introducing smaller portions and tapas-style menus to adapt.

Shotlee·Apr 4, 2026·4 min read

GLP-1 Medications

Emcure Revises Poviztra Semaglutide Price to ₹3,999/Month in India

Emcure Pharmaceuticals is slashing the price of Poviztra semaglutide injection to ₹3,999 per month starting April 3, 2026, making this weight management therapy more accessible across India. As the first Indian firm offering this second brand of Novo Nordisk's semaglutide, Emcure aims to tackle the nation's obesity epidemic affecting over 600 million adults. Backed by 49 million patient years and 50 clinical trials, Poviztra promises validated support for obesity-linked conditions.

Shotlee·Apr 3, 2026·5 min read

Telehealth & GLP-1

Entrepreneur Uses AI to Build $1B Telehealth Company on GLP-1 Drugs

Matthew Gallagher, a 41-year-old LA entrepreneur, turned $20,000 into a nearly $2 billion telehealth empire with AI alone. Medvi sells GLP-1 drugs like Ozempic at $300 versus $1,000 retail, serving 250,000 customers. But rapid growth sparks debates on legality and fake ads.

Shotlee·Apr 3, 2026·5 min read

GLP-1 Medications

India's 'Mounjaro Brides': Weight-Loss Injections in Pre-Wedding Prep

In India, 'Mounjaro brides' are using weight-loss injections as part of pre-wedding rituals, driven by intense societal expectations. Clinics like Klarity Skin Clinic offer specialized packages, while doctors report a surge in queries from brides and grooms. This trend highlights both the drugs' popularity and the need for medical supervision.

Shotlee·Apr 3, 2026·5 min read

GLP-1 Medications News

Man Wanted for Stealing £12k Mounjaro After Court No-Show

A 27-year-old man from Wigan is being hunted by police after failing to appear in court on charges of stealing over £12,000 worth of Mounjaro weight loss injections from his workplace. The theft highlights the skyrocketing demand for this GLP-1 medication used for type 2 diabetes and appetite control. Understand the case details and what makes Mounjaro so sought after.

Shotlee·Apr 3, 2026·4 min read

GLP-1 Medications

JD Vance Sparks Ozempic Rumors With Slimmer Appearance

Vice President JD Vance appeared noticeably slimmer in a recent interview with Benny Johnson, igniting Ozempic rumors across X. Netizens speculate on the popular weight-loss drug amid past denials and critic backlash. While no confirmation exists, the buzz highlights Ozempic's role in metabolic health conversations.

Shotlee·Apr 3, 2026·5 min read

Metabolic Health

Latest Articles

FDA Approves Foundayo Weight Loss Pill, Igniting GLP-1 Showdown

MHRA Investigates UK Peptide Clinics Over Health Claims

Doctor Warns of 'Miserable' Constipation from Wegovy as NHS Expands to 1.2M

Ozempic Users Reshape How America Dines Out

Emcure Revises Poviztra Semaglutide Price to ₹3,999/Month in India

Entrepreneur Uses AI to Build $1B Telehealth Company on GLP-1 Drugs

India's 'Mounjaro Brides': Weight-Loss Injections in Pre-Wedding Prep

Man Wanted for Stealing £12k Mounjaro After Court No-Show

JD Vance Sparks Ozempic Rumors With Slimmer Appearance

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

Beyond Healthspan: The New Midlife Goal for Men

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Study Finds Some Patients Keep Weight Off with Fewer GLP-1 Injections

Doctor Issues Warning About Overlooked Mounjaro Side Effect